DE69939106D1 - Verfahren zur Herstellung von ED-71 - Google Patents
Verfahren zur Herstellung von ED-71Info
- Publication number
- DE69939106D1 DE69939106D1 DE69939106T DE69939106T DE69939106D1 DE 69939106 D1 DE69939106 D1 DE 69939106D1 DE 69939106 T DE69939106 T DE 69939106T DE 69939106 T DE69939106 T DE 69939106T DE 69939106 D1 DE69939106 D1 DE 69939106D1
- Authority
- DE
- Germany
- Prior art keywords
- vitamin
- derivatives
- protective group
- represents hydrogen
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000006239 protecting group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/44—Halogenated unsaturated alcohols containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
- C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
- C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4229598 | 1998-02-24 | ||
PCT/JP1999/000796 WO1999043645A1 (fr) | 1998-02-24 | 1999-02-23 | Derives de 24-hydroxyvitamine d |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69939106D1 true DE69939106D1 (de) | 2008-08-28 |
Family
ID=12632059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69939106T Expired - Lifetime DE69939106D1 (de) | 1998-02-24 | 1999-02-23 | Verfahren zur Herstellung von ED-71 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1061070B1 (de) |
JP (2) | JP4357114B2 (de) |
AT (1) | ATE401303T1 (de) |
AU (1) | AU2549099A (de) |
DE (1) | DE69939106D1 (de) |
WO (1) | WO1999043645A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE341533T1 (de) * | 1998-02-27 | 2006-10-15 | Chugai Pharmaceutical Co Ltd | Intermediat für die synthese des a-ringteils von vitamin d derivaten mit einem substituenten in der 2-position |
EP1812011A1 (de) | 2004-11-12 | 2007-08-01 | Bioxell S.p.a. | Kombinierte verwendung von vitamin-d-derivaten und antiproliferativen mitteln zur behandlung von blasenkrebs |
WO2008062871A1 (fr) | 2006-11-22 | 2008-05-29 | Shiseido Company Ltd. | Procédé de production d'une poudre de fines particules d'oxyde de zinc et de cosmétiques contenant la poudre |
BRPI0916600B1 (pt) | 2008-07-18 | 2020-09-15 | Basf Se | Processo para a preparação de partículas de zno modificadas, partículas de zno modificadas, processo para a incorporação de partículas de zno modificadas em materiais, e, uso de partículas de zno modificadas |
BR112013009647A2 (pt) | 2010-10-25 | 2016-07-12 | Teijin Pharma Ltd | derivado de vitamina, composição farmacêutica, agente terapêutico, e, composto |
TW201406380A (zh) * | 2012-04-24 | 2014-02-16 | Teijin Pharma Ltd | 次發性副甲狀腺機能亢進症治療劑 |
ES2969990T3 (es) * | 2019-05-13 | 2024-05-23 | Faes Farma Sa | Procedimiento y productos intermedios para la preparación de eldecalcitol |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51108048A (en) * | 1975-03-17 | 1976-09-25 | Teijin Ltd | 1 arufua * 24 * s * *255 torihidokishikorekarushifuerooruno seizoho |
JPS5846507B2 (ja) * | 1978-12-26 | 1983-10-17 | 帝人株式会社 | 1α,24(R),25↓−トリヒドロキシコレカルシフエロ−ルの製造法 |
JPS58208223A (ja) * | 1982-05-28 | 1983-12-03 | Kureha Chem Ind Co Ltd | 抗腫瘍剤 |
US4666634A (en) * | 1984-12-05 | 1987-05-19 | Chugai Seiyaku Kabushiki Kaisha | vitamin D3 derivatives having a substituent at 2-position |
JPH0780773B2 (ja) * | 1986-06-05 | 1995-08-30 | 中外製薬株式会社 | 新規ビタミンd▲下3▼誘導体を有効成分とする医薬 |
DE69433220T2 (de) * | 1993-07-09 | 2004-08-19 | Laboratoire Theramex | Neue strukturelle Vitamin D Derivate |
JP3712077B2 (ja) * | 1995-05-12 | 2005-11-02 | 株式会社クラレ | ヒドロインダン−4−オール誘導体およびその製造方法 |
JPH11130711A (ja) * | 1997-10-24 | 1999-05-18 | Teijin Ltd | 1α,24,25−トリヒドロキシビタミンD3類の合成中間体およびその製造法 |
ATE341533T1 (de) * | 1998-02-27 | 2006-10-15 | Chugai Pharmaceutical Co Ltd | Intermediat für die synthese des a-ringteils von vitamin d derivaten mit einem substituenten in der 2-position |
-
1999
- 1999-02-23 DE DE69939106T patent/DE69939106D1/de not_active Expired - Lifetime
- 1999-02-23 AU AU25490/99A patent/AU2549099A/en not_active Abandoned
- 1999-02-23 JP JP2000533404A patent/JP4357114B2/ja not_active Expired - Fee Related
- 1999-02-23 WO PCT/JP1999/000796 patent/WO1999043645A1/ja active IP Right Grant
- 1999-02-23 AT AT99905280T patent/ATE401303T1/de not_active IP Right Cessation
- 1999-02-23 EP EP99905280A patent/EP1061070B1/de not_active Expired - Lifetime
-
2009
- 2009-06-23 JP JP2009148244A patent/JP4990937B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1061070A1 (de) | 2000-12-20 |
AU2549099A (en) | 1999-09-15 |
JP4990937B2 (ja) | 2012-08-01 |
EP1061070B1 (de) | 2008-07-16 |
ATE401303T1 (de) | 2008-08-15 |
WO1999043645A1 (fr) | 1999-09-02 |
JP4357114B2 (ja) | 2009-11-04 |
EP1061070A4 (de) | 2005-03-30 |
JP2009256361A (ja) | 2009-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE267822T1 (de) | Verfahren zur herstellung von luteolin und luteolin-derivaten | |
ATE132145T1 (de) | Verfahren zur herstellung von bacchatin iii und von desacetyl-10-bacchatin iii derivate | |
ATE148610T1 (de) | Antimikrobielle mittel sowie substituierte 2- cyclohexan-1-yl-amin-derivate und deren herstellung | |
DE69113155D1 (de) | 17-beta-substituierte-4-aza-5-alpha-androstan-3-one-derivate und verfahren zu ihrer herstellung. | |
ATE129503T1 (de) | Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien. | |
ES2123039T3 (es) | Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
ATE246196T1 (de) | Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon | |
DE69838146D1 (de) | Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben | |
MY101841A (en) | Insecticidal trifluormethyl alkane derivatives. | |
ATE134623T1 (de) | Salicyl(thio)etherderivate, verfahren und zwischenprodukte zu ihrer herstellung | |
DE69939106D1 (de) | Verfahren zur Herstellung von ED-71 | |
ATE152118T1 (de) | Kardioaktive 17b-(3-furyl) und 17b-(4- pyridazinyl)-5beta, 14beta-androstan derivate, verfahren zu ihrer herstellung und pharmazeutische präparate davon | |
DE60235365D1 (de) | Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung | |
MX9708735A (es) | Benzotiazoles y benzoxazoles, composiciones farmaceuticas que contienen estos compuestos y su uso y proceso para prepararlos. | |
ATE172976T1 (de) | 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE59106966D1 (de) | Verfahren zur Herstellung von 3-Amino-2-(het)aroyl-acrylsäurederivaten. | |
DE69300453D1 (de) | Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen. | |
AU639154B2 (en) | New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them | |
ATE170520T1 (de) | Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE267832T1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
DE3887102D1 (de) | Substituierte Derivate von 20,21-Dinoreburnamenin, Verfahren zur Herstellung und so hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen. | |
DE69312512D1 (de) | Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels | |
ES2027492A6 (es) | Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables. | |
ATE111093T1 (de) | Verfahren zur herstellung von enantiomeren von 3- aminchromanderivaten. | |
DE69208502D1 (de) | Alphamethylen-5-Thiazoloessigsäurederivate, Zwischenprodukte und Verfahren zur Herstellung, ihre Anwendung als Fongizide und diese enthaltende Zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |